Literature DB >> 16520942

Birth length and weight in congenital adrenal hyperplasia according to the different phenotypes.

Antonio Balsamo1, Malgorzata Wasniewska, Giuseppe Di Pasquale, Giuseppina Salzano, Federico Baronio, Sara Bombaci, Filippo De Luca.   

Abstract

UNLABELLED: The aims of this study were to: (1) retrospectively investigate the birth length and weight of our patients with congenital adrenal hyperplasia (CAH); (2) compare these parameters with standards for birth length and weight recently assessed in an Italian control population; (3) evaluate whether neonatal auxological data may change depending on the different clinical forms of CAH. Birth length and weight were retrospectively evaluated in 101 children with different clinical forms of CAH and compared with standards for birth length and weight assessed in an Italian control population. In both sexes the average birth length of patients with classical CAH was greater than the mean birth length of the controls, and both length and weight were greater in children with classical CAH than in those with the non-classical form. Among the patients with classical CAH, those with the salt-wasting form were longer but also weighed less than those with the simple-virilizing form.
CONCLUSIONS: (1) fetal length velocity in patients with CAH may be increased only in those infants with classical forms of the syndrome, while it is unaffected in those with the non-classical form; (2) the greater the enzymatic activity impairment, the longer the birth length of newborns with CAH.

Entities:  

Mesh:

Year:  2006        PMID: 16520942     DOI: 10.1007/s00431-005-0075-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

Review 1.  Congenital adrenal hyperplasia.

Authors:  Phyllis W Speiser; Perrin C White
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

Review 2.  Endocrine and nutritional regulation of prenatal growth.

Authors:  P D Gluckman
Journal:  Acta Paediatr Suppl       Date:  1997-11

3.  Molecular basis of nonclassical steroid 21-hydroxylase deficiency detected by neonatal mass screening in Japan.

Authors:  T Tajima; K Fujieda; J Nakae; T Toyoura; K Shimozawa; S Kusuda; K Goji; T Nagashima; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

4.  Fetal growth: boys before girls.

Authors:  F de Zegher; H Devlieger; R Eeckels
Journal:  Horm Res       Date:  1999

5.  Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.

Authors:  J Jääskeläinen; R Voutilainen
Journal:  Pediatr Res       Date:  1997-01       Impact factor: 3.756

6.  Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

Authors:  B L Therrell; S A Berenbaum; V Manter-Kapanke; J Simmank; K Korman; L Prentice; J Gonzalez; S Gunn
Journal:  Pediatrics       Date:  1998-04       Impact factor: 7.124

7.  Serum cortisol and cortisone levels in newborns with congenital adrenal hyperplasia before the start of therapy.

Authors:  J Dötsch; I Hohenberger; F G Riepe; W G Sippell; H G Dörr
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

Review 8.  Mineralocorticoids in congenital adrenal hyperplasia.

Authors:  E G Biglieri; C E Kater
Journal:  J Steroid Biochem Mol Biol       Date:  1991       Impact factor: 4.292

9.  Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.

Authors:  M Barbaro; S Lajic; L Baldazzi; A Balsamo; P Pirazzoli; A Cicognani; A Wedell; E Cacciari
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

10.  Genotyping steroid 21-hydroxylase deficiency: hormonal reference data.

Authors:  M I New; F Lorenzen; A J Lerner; B Kohn; S E Oberfield; M S Pollack; B Dupont; E Stoner; D J Levy; S Pang; L S Levine
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

View more
  4 in total

1.  Novel nonsense mutation (W22X) in CYP21A2 gene causing salt-wasting congenital adrenal hyperplasia in a compound heterozygous girl.

Authors:  L Di Pasquale; S Indovina; M Wasniewska; S Mirabelli; P Porcelli; I Rulli; G Salzano; F De Luca
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

2.  Childhood growth in boys with congenital hypogonadotropic hypogonadism.

Authors:  Tero Varimo; Matti Hero; Eeva-Maria Laitinen; Päivi J Miettinen; Johanna Tommiska; Johanna Känsäkoski; Anders Juul; Taneli Raivio
Journal:  Pediatr Res       Date:  2015-12-31       Impact factor: 3.756

3.  Growth and reproductive outcomes in congenital adrenal hyperplasia.

Authors:  Todd D Nebesio; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2010-02-01

4.  Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Laura J Chalmers; Paul Doherty; Claude J Migeon; Kenneth C Copeland; Brianna C Bright; Amy B Wisniewski
Journal:  Biol Sex Differ       Date:  2011-05-05       Impact factor: 5.027

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.